Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelagliptin vs Sitagliptin in Type 2 Diabetes
NCT07073768Phase 3Enrolling by invitation
- Sponsor
- Khyber Medical College
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Khyber Medical College. Started Jul 2025; status: enrolling by invitation.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07073768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07073768.